Removal of Problematic Host Cell Proteins—What’s Next?
Exploding demand, increasing FDA drug approvals, and promising pipelines continue to invite significant investment in the biopharmaceutical industry. The call to make drugs faster, cheaper, safer, and more efficiently has never been more piercing, yet the bioprocessing and manufacturing of biopharmaceuticals are not without challenges at every turn. One of the key purification challenges is the separation of host cell proteins (HCPs) from the product of interest.
Learn how 3M is providing platforms to address these challenges and the potential breakthroughs for the removal of problematic HCP.
Download this complimentary article to discover:
- Manufacturing Imperatives in a Growth Industry
- Challenges in HCP Removal
- Current Industry Approaches to HCP Removal Challenges
- The Future of HCP Removal
Download the Complimentary Article
"*" indicates required fields